## Core Concept
The development of resistance to anti-tuberculosis drugs is a major concern in the treatment and control of tuberculosis (TB). Resistance in TB primarily arises due to genetic mutations in the target bacteria, *Mycobacterium tuberculosis*, rather than through acquired immunity or other indirect mechanisms.

## Why the Correct Answer is Right
The correct answer, **C. Genetic mutation**, highlights the primary mechanism through which *Mycobacterium tuberculosis* develops resistance to anti-tuberculosis drugs. This occurs due to spontaneous mutations in the bacterial DNA that alter the drug's target, reduce drug accumulation, or modify the drug itself. The most common mutations leading to resistance are in the *rpoB* gene for rifampicin and the *katG* gene for isoniazid. These mutations are selected for and become dominant in the bacterial population when patients are exposed to inadequate or incomplete treatment regimens, allowing the drug-susceptible bacteria to be killed while the resistant mutants survive and multiply.

## Why Each Wrong Option is Incorrect
- **Option A: Efflux pumps** play a role in reducing the intracellular concentration of certain drugs by pumping them out of the cell, but this is not the most important mechanism for developing resistance to first-line anti-tuberculosis drugs.
- **Option B: Enzyme inactivation** can contribute to drug resistance, for example, through the modification of drug targets or through the production of enzymes that degrade the drug. However, this is not the primary mechanism for resistance development in TB.
- **Option D: Horizontal gene transfer** can spread resistance genes between bacteria, but this is not the most significant mechanism for the development of resistance to anti-tuberculosis drugs in *Mycobacterium tuberculosis*.

## Clinical Pearl / High-Yield Fact
A critical point to remember is that the use of a single drug to treat TB almost invariably leads to the development of resistance. Therefore, TB treatment involves a combination of multiple drugs from the outset to prevent the selection and proliferation of drug-resistant mutants. This approach is crucial for curing the individual patient and preventing the spread of drug-resistant TB.

## Correct Answer: C. Genetic mutation